SEC Form 4 · accession 0001013606-15-000054
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory D Waller
Director
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 1:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | M | 15,853 | $8.26 | A | 37,742 | D | |
| Common StockF1 | May 20, 2015 | S | 15,853 | $16.70 | D | 21,843 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $8.26 | May 20, 2015 | M | 15,853 | D | May 25, 2012 | May 25, 2021 | Common Stock | 15,853 | 0 | D |
Explanation of responses
- F1The price reported is a weighted average price. These shares were sold in multiple transactions at price ranging from $16.60 to 16.76. The Reporting Person undertakes to provide Endologix, Inc., any security holder of Endologix, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each price within the ranges set forth in this Form 4.